Physicians Toxicology Laboratory, LLC

Physicians Toxicology Laboratory, LLC was paid $6.08M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 55% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#13 of 225

Median peer was paid$74K

This provider vs. median83×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	24,036	$944K
2019	44,435	$1.19M
2020	30,666	$881K
2021	28,807	$962K
2022	10,410	$614K
2023	31,309	$663K
2024incomplete	32,613	$825K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	55%	53,266	38,478	$3.32M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	21%	60,255	41,557	$1.27M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	11%	20,199	12,626	$690K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	2.5%	4,802	3,727	$154K
84403		2.3%	7,633	4,789	$139K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.3%	5,358	3,994	$138K
82530		<1%	6,183	5,054	$45K
80330		<1%	690	516	$36K
82157		<1%	2,821	2,331	$31K
82679		<1%	3,127	2,562	$27K
80334		<1%	451	321	$25K
84144		<1%	3,464	2,813	$24K

43 more codes

82626		<1%	2,681	$21K
80337		<1%	332	$21K
80323		<1%	847	$18K
82542		<1%	5,745	$14K
80321		<1%	710	$12K
80355		<1%	1,158	$11K
80346		<1%	1,148	$10K
80338		<1%	781	$8K
80336		<1%	152	$8K
80370		<1%	1,105	$7K
80366		<1%	337	$4K
80364		<1%	360	$3K
80373		<1%	1,193	$3K
80372		<1%	1,176	$3K
80326		<1%	730	$3K
80332		<1%	135	$3K
80368		<1%	1,123	$2K
80335		<1%	89	$2K
80357		<1%	1,113	$2K
80361		<1%	1,489	$2K
80350		<1%	719	$1K
80356		<1%	1,177	$1K
80354		<1%	1,207	$1K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	13	$1K
80358		<1%	1,175	$944.92
80365		<1%	1,271	$938.90
80371		<1%	778	$884.27
80360		<1%	670	$729.46
80348		<1%	1,090	$613.17
80155		<1%	155	$562.63
80363		<1%	394	$351.29
80305		<1%	36	$231.71
80414		<1%	196	$140.26
80349		<1%	494	$113.34
80353		<1%	385	$100.36
80362		<1%	154	$57.33
80359		<1%	221	$42.44
83992		<1%	91	$35.13
80345		<1%	768	$31.90
80324		<1%	156	$31.83
84311		<1%	375	$24.68
80367		0%	13	$0.00
80375		0%	85	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCLOONAN, JAMES (PRESIDENT)

Parent organizationPHYSICIANS TOXICOLOGY LABORATORY, LLC